Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
Current nutritional approaches to metabolic syndrome and type 2 diabetes generally rely on reductions in dietary fat. The success of such approaches has been limited and therapy more generally relies on pharmacology. The argument is made that a re-evaluation of the role of carbohydrate restriction, the historical and intuitive approach to the problem, may provide an alternative and possibly superior dietary strategy. The rationale is that carbohydrate restriction improves glycemic control and reduces insulin fluctuations which are primary targets. Experiments are summarized showing that carbohydrate-restricted diets are at least as effective for weight loss as low-fat diets and that substitution of fat for carbohydrate is generally beneficial for risk of cardiovascular disease. These beneficial effects of carbohydrate restriction do not require weight loss. Finally, the point is reiterated that carbohydrate restriction improves all of the features of metabolic syndrome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Glucose and Insulin response for patients with type 2 diabetes on low carbohydrate diet vs. control. Data (means ± SE) are for 9 patients with type 2 diabetes after seven days on their usual high-carbohydrate diet (control) and after 2 weeks) on a low-carbohydrate diet. Medication was reduced in 4 patients and discontinued in one during the low-carbohydrate diet. Figure redrawn from Boden, et al. [8].](https://figures.cochat.ai/paper-figures/d443347303b945e69d2735d90979f4ef/dietary-carbohydrate-restriction-in-type-2-diabetes-mellitus-and-metabolic-figure-1.jpg)
![Figure 2 Comparison of low and high carbohydrate diets at 6 and 12 months. Results from a multi-center trial in which 63 obese men and women were randomly assigned to either diet. Data from Foster, et al. [26]. Figure from Volek & Feinman [24], used with permission. DBP, diastolic blood pressure; TAG, triglycerides.](https://figures.cochat.ai/paper-figures/71c76dbe00f747cd874844f4bbbc50f6/dietary-carbohydrate-restriction-in-type-2-diabetes-mellitus-and-metabolic-figure-2.jpg)
![Figure 3 Effect of dietary interventions on reduction in triglycerides. Eucaloric diets of indicated carbohydrate content were begun at time 0. At week 3, a 1000 kcal reduction in energy was implemented and at week 9, dieters were put on maintenance diet. Combined effect of calorie reduction and maintenance are reported at week 12. Solid Lines: data from Krauss, et al. [58] were converted from reported log values in their Table 2 and per cent of baseline was calculated. Dashed line: data from Sharman, et al [56]: A eucaloric ketogenic diet was instituted for six weeks (no weight loss phase). Points were recorded at week 3 and 6. Figure modified from Feinman & Volek [57]. Similar results were found for HDL, apoB/apoA1 and other markers of CVD [57, 58]](https://figures.cochat.ai/paper-figures/a18b6ec9bd754fdab31e43e7addeabf9/dietary-carbohydrate-restriction-in-type-2-diabetes-mellitus-and-metabolic-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Considering low HDL and high triglyceride levels being independent risk factors for insulin resistance and cardiovascular disorders [58]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811 · cited 1×
“Replacement of saturated fat with carbohydrate, however, is almost always deleterious [46,47].”
BackgroundBantle (2008) · doi:10.2337/dc08-s061 · Cited by 1,795
A Randomized Trial of a Low-Carbohydrate Diet for Obesity
Foster, G. D., Wyatt, H. R., Hill, J. O., McGuckin, B. G., Brill, C., Mohammed, B. S., Szapary, P. O., Rader, D. J., Edman, J. S., & Klein, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022207 · Cited by 1,794 · cited 1×
“[26] and Samaha, et al.”
Dietary Fat Intake and the Risk of Coronary Heart Disease in Women
Hu, F. B., Stampfer, M. J., Manson, J. E., Rimm, E., Colditz, G. A., Rosner, B. A., Hennekens, C. H., & Willett, W. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372102 · Cited by 1,782
CORONARY HEART DISEASE IN SEVEN COUNTRIES
(1971) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1971.tb50629.x · Cited by 1,599
A Low-Carbohydrate as Compared with a Low-Fat Diet in Severe Obesity
Samaha, F. F., Iqbal, N., Seshadri, P., Chicano, K. L., Daily, D. A., McGrory, J., Williams, T., Williams, M., Gracely, E. J., & Stern, L. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022637 · Cited by 1,267 · cited 1×
“[27] are often cited as examples where low carbohydrate diets are more effective at 6 months but no better than low-fat diets at 1 year.”
BackgroundHoward, B. V., Van Horn, L., Hsia, J., Manson, J. E., Stefanick, M. L., Wassertheil-Smoller, S., Kuller, L. H., LaCroix, A. Z., Langer, R. D., Lasser, N. L., et al. (2006) · JAMA · doi:10.1001/jama.295.6.655 · Cited by 1,091
The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome
Petersen, K. F., Dufour, S., Savage, D. B., Bilz, S., Solomon, G., Yonemitsu, S., Cline, G. W., Befroy, D., Zemany, L., Kahn, B. B., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705408104 · Cited by 759
Coronary Heart Disease in Seven Countries.
(1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-6-1026_8 · Cited by 758
McLaughlin, T., Reaven, G., Abbasi, F., Lamendola, C., Saad, M., Waters, D., Simon, J., & Krauss, R. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.085 · Cited by 658 · cited 1×
“Indeed, the triglyceride:HDL ratio has been posited to be a surrogate measure of insulin resistance [ 38 ].”
BackgroundBoden, G., Sargrad, K., Homko, C., Mozzoli, M., & Stein, T. P. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-6-200503150-00006 · Cited by 542
Regulation of Plasma Triglycerides in Insulin Resistance and Diabetes
Ginsberg, H. N., Zhang, Y.-L., & Hernandez-Ono, A. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.005 · Cited by 531 · cited 1×
“Of particular importance is circulating TG because of its mechanistic link to the formation of atherogenic particles [40,41], and its responsiveness to dietary manipulation.”
BackgroundEvidence-based nutritional approaches to the treatment and prevention of diabetes mellitus
Mann, J. I., De Leeuw, I., Hermansen, K., Karamanos, B., Karlström, B., Katsilambros, N., Riccardi, G., Rivellese, A. A., Rizkalla, S., Slama, G., et al. (2004) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/s0939-4753(04)80028-0 · Cited by 527
Dr. Atkins' New Diet Revolution
Atkins, R. C. (1973) · Cited by 467
Krieger, J. W., Sitren, H. S., Daniels, M. J., & Langkamp-Henken, B. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.260 · Cited by 466
BARTER, P. J., BALLANTYNE, C. M., CARMENA, R., CABEZAS, M. C., CHAPMAN, M. J., COUTURE, P., DE GRAAF, J., DURRINGTON, P. N., FAERGEMAN, O., FROHLICH, J., et al. (2006) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01616.x · Cited by 464 · cited 2×
“An increase in apolipoprotein B (apoB) may be a preferred marker since each atherogenic lipoprotein particle contains one molecule of apoB; total LDL would bias results towards lower risk [39].”
BackgroundGarg, A. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510420053034 · Cited by 392 · cited 2×
“Practical considerations and recommendations Definitions and recommendations Response to carbohydrate restriction shows both continuous, graded outcomes [17, 18 ] as well as a threshold effects.”
BackgroundDraznin, B. (2006) · Diabetes · doi:10.2337/db06-0391 · Cited by 388 · cited 1×
“[4,5]) but, according to the view considered here, dietary fat has a generally passive role and deleterious effects of fat are almost always seen in the presence of high carbohydrate.”
BackgroundSelf-citationLow-carbohydrate nutrition and metabolism
Westman, E. C., Feinman, R. D., Mavropoulos, J. C., Vernon, M. C., Volek, J. S., Wortman, J. A., Yancy, W. S., & Phinney, S. D. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/86.2.276 · Cited by 379 · cited 1×
“Low-carbohydrate diets generally perform better than low-fat diets for weight loss in normal subjects, and patients with metabolic syndrome or diabetes [22-25].”
BackgroundSelf-citationForsythe, C. E., Phinney, S. D., Fernandez, M. L., Quann, E. E., Wood, R. J., Bibus, D. M., Kraemer, W. J., Feinman, R. D., & Volek, J. S. (2008) · Lipids · doi:10.1007/s11745-007-3132-7 · Cited by 371 · cited 5×
“low-fat (LF) diet (56:24) and found that after 12 weeks, SFA in TG and cholesteryl ester were lower in the VLCK group than the LF group even thought the low carbohydrate group had a 3-fold higher intake of dietary SFA [50].”
BackgroundInfluentialSelf-citationSeparate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia
Krauss, R. M., Blanche, P. J., Rawlings, R. S., Fernstrom, H. S., & Williams, P. T. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.5.1025 · Cited by 321 · cited 13×
“Substitution of fat for carbohydrate is generally beneficial for markers for and incidence of CVD.”
BackgroundMethodResultInfluentialA ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men
Sharman, M. J., Kraemer, W. J., Love, D. M., Avery, N. G., Gómez, A. L., Scheett, T. P., & Volek, J. S. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.7.1879 · Cited by 312 · cited 2×
“Dashed line: data from Sharman, et al [56]: A eucaloric ketogenic diet was instituted for six weeks (no weight loss phase).”
BackgroundMethodSelf-citationSaturated fats: what dietary intake?
German, J. B., & Dillard, C. J. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.550 · Cited by 292 · cited 2×
“Several critical reviews have pointed up the general failure to meet the kind of unambiguous outcomes that would justify blanket condemnation of saturated fat, per se [29,30,41,43,44].”
BackgroundDietary fat, fatty acid composition in plasma and the metabolic syndrome
Vessby, B. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200302000-00004 · Cited by 291 · cited 1×
“The assumption that the dietary fatty acid profile is reflected in plasma distribution is not always true, especially for saturated fatty acids which seems to be subject to much metabolic processing [42].”
BackgroundA low-carbohydrate, ketogenic diet to treat type 2 diabetes
Yancy, W. S., Foy, M., Chalecki, A. M., Vernon, M. C., & Westman, E. C. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-34 · Cited by 270 · cited 2×
“[8, 62 ,63] A reduced carbohydrate diet may show significant per cent increase in fat, but there may be no change in the absolute amount consumed.”
BackgroundSelf-citationLê, K.-A., & Tappy, L. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232910.61612.4d · Cited by 248 · cited 1×
“Fructose consumption has been implicated in the epidemics of obesity, MetS, and type 2 diabetes and is known to induce hypertension, de novo lipogenesis, hepatic insulin resistance and adiposity [52-54].”
BackgroundFructose and the Metabolic Syndrome: Pathophysiology and Molecular Mechanisms
Rutledge, A. C., & Adeli, K. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00322.x · Cited by 240 · cited 1×
“Fructose consumption has been implicated in the epidemics of obesity, MetS, and type 2 diabetes and is known to induce hypertension, de novo lipogenesis, hepatic insulin resistance and adiposity [52-54].”
BackgroundNutrition Recommendations and Interventions for Diabetes
American Diabetes Association (2007) · Diabetes Care · doi:10.2337/dc07-s048 · Cited by 234
Volek, J. S., & Feinman, R. D. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-31 · Cited by 226
Self-citationFructose and the Metabolic Syndrome: Pathophysiology and Molecular Mechanisms
Rutledge, A. C., & Adeli, K. (2007) · Nutrition Reviews · doi:10.1301/nr.2007.jun.s13-s23 · Cited by 215
Low‐density lipoprotein subclass patterns and lipoprotein response to a reduced‐fat diet in men
Dreon, D. M., Fernstrom, H. A., Miller, B., & Krauss, R. M. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.1.8299884 · Cited by 196 · cited 3×
“Clinically significant elevation of LDL-cholesterol is generally considered a primary indicator of CVD risk but interpretation must be tempered by the effect of particle size: small dense LDL particles are significantly more atherogenic than large, buoyant LDL particles [36,37].”
BackgroundDietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women
Mozaffarian, D., Rimm, E. B., & Herrington, D. M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.5.1175 · Cited by 183 · cited 2×
“Perhaps most remarkable was a study by Mozaffarian [45] which showed that greater intake of saturated fat was associated with reduced progression of coronary atherosclerosis; greater carbohydrate intake was linked to increased progression.”
BackgroundVolek, J., Sharman, M., Gómez, A., Judelson, D., Rubin, M., Watson, G., Sokmen, B., Silvestre, R., French, D., & Kraemer, W. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-13 · Cited by 175 · cited 1×
“[8,62,63] A reduced carbohydrate diet may show significant per cent increase in fat, but there may be no change in the absolute amount consumed.”
Self-citationThe Questionable Role of Saturated and Polyunsaturated Fatty Acids in Cardiovascular Disease
Ravnskov, U. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00018-3 · Cited by 172 · cited 1×
“Several critical reviews have pointed up the general failure to meet the kind of unambiguous outcomes that would justify blanket condemnation of saturated fat, per se [29,30,41,43,44].”
BackgroundSelf-citationBeneficial effects of ketogenic diet in obese diabetic subjects
Dashti, H. M., Mathew, T. C., Khadada, M., Al-Mousawi, M., Talib, H., Asfar, S. K., Behbahani, A. I., & Al-Zaid, N. S. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9448-z · Cited by 171 · cited 1×
“Normal levels were reached by week 48 [9].”
BackgroundDreon, D., Fernstrom, H., Campos, H., Blanche, P., Williams, P., & Krauss, R. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.5.828 · Cited by 170 · cited 2×
“Several critical reviews have pointed up the general failure to meet the kind of unambiguous outcomes that would justify blanket condemnation of saturated fat, per se [29,30,41,43,44].”
BackgroundTotal Fat Intake Modifies Plasma Fatty Acid Composition in Humans
Raatz, S. K., Bibus, D., Thomas, W., & Kris-Etherton, P. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.2.231 · Cited by 167 · cited 1×
“showed that such differences were extremely small between a low fat and high fat diet [48].”
BackgroundLustig, R. H. (2006) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0220 · Cited by 160 · cited 1×
“A simpler alternative hypothesis considers that insulin resistance represents a down-regulation of hormonal response as a result of persistent high levels of insulin, a feature common to other hormonal systems [55].”
BackgroundSelf-citationModification of Lipoproteins by Very Low-Carbohydrate Diets
Volek, J. S., Sharman, M. J., & Forsythe, C. E. (2005) · The Journal of Nutrition · doi:10.1093/jn/135.6.1339 · Cited by 159 · cited 3×
“Several critical reviews have pointed up the general failure to meet the kind of unambiguous outcomes that would justify blanket condemnation of saturated fat, per se [29,30,41,43,44].”
BackgroundSelf-citationCoronary heart disease in seven countries
Keys, A. (1997) · Nutrition · doi:10.1016/s0899-9007(96)00410-8 · Cited by 154
Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition
Gannon, M. C., & Nuttall, F. Q. (2006) · Nutrition & Metabolism · doi:10.1186/1743-7075-3-16 · Cited by 134
Nielsen, J. V., & Joensson, E. A. (2008) · Nutrition & Metabolism · doi:10.1186/1743-7075-5-14 · Cited by 128
Self-citationDaly, M. E., Paisey, R., Paisey, R., Millward, B. A., Eccles, C., Williams, K., Hammersley, S., MacLeod, K. M., & Gale, T. J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01760.x · Cited by 127 · cited 1×
“Many studies have demonstrated the benefits of carbohydrate reduction [11-16] on glycemic control.”
BackgroundEffects of high-protein, low-carbohydrate dieting on plasma lipoproteins and body weight
LAROSA, J. C., FRY, A. G., MUESING, R., & ROSING, D. R. (1980) · Journal of the American Dietetic Association · doi:10.1016/s1094-7159(21)03514-5 · Cited by 116 · cited 1×
“First shown by LaRosa, [61] it has now been observed by many other investigators.”
ResultAtherogenic Lipoprotein Phenotype and Diet-Gene Interactions
Krauss, R. M. (2001) · Journal of Nutrition · doi:10.1093/jn/131.2.340s · Cited by 111 · cited 3×
“Clinically significant elevation of LDL-cholesterol is generally considered a primary indicator of CVD risk but interpretation must be tempered by the effect of particle size: small dense LDL particles are significantly more atherogenic than large, buoyant LDL particles [36,37].”
BackgroundThermodynamics and Metabolic Advantage of Weight Loss Diets
Feinman, R. D., & Fine, E. J. (2003) · Metabolic Syndrome and Related Disorders · doi:10.1089/154041903322716688 · Cited by 98
Self-citationGarg, A. (1994) · JAMA · doi:10.1001/jama.271.18.1421 · Cited by 93
Atherosclerosis in diabetes and insulin resistance
Reusch, J. E. B., & Draznin, B. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00620.x · Cited by 64 · cited 1×
“[4,5]) but, according to the view considered here, dietary fat has a generally passive role and deleterious effects of fat are almost always seen in the presence of high carbohydrate.”
BackgroundSelf-citationA Low Carbohydrate Diet in Type 1 Diabetes
Nielsen, J. V., Jönsson, E., & Ivarsson, A. (2005) · Upsala Journal of Medical Sciences · doi:10.3109/2000-1967-074 · Cited by 64 · cited 1×
“The discussion focuses on type 2 diabetes but many of the principles will apply to metabolic syndrome and possibly to type 1 as well[6, 7 ].”
BackgroundSelf-citationNielsen, J. V., & Joensson, E. (2006) · Nutrition & Metabolism · doi:10.1186/1743-7075-3-22 · Cited by 63
Self-citationLow carbohydrate diets improve atherogenic dyslipidemia even in the absence of weight loss
Feinman, R. D., & Volek, J. S. (2006) · Nutrition & Metabolism · doi:10.1186/1743-7075-3-24 · Cited by 57 · cited 13×
“Substitution of fat for carbohydrate is generally beneficial for markers for and incidence of CVD.”
BackgroundResultInfluentialSelf-citationThe South Beach Diet: Weighing the Pros and Cons
Schnirring, L. (2004) · The Physician and Sportsmedicine · doi:10.3810/psm.2004.01.70 · Cited by 55
Nielsen, J. V., Jönsson, E., & Nilsson, A.-K. (2005) · Upsala Journal of Medical Sciences · doi:10.3109/2000-1967-182 · Cited by 52
Self-citationAllick, G., Bisschop, P. H., Ackermans, M. T., Endert, E., Meijer, A. J., Kuipers, F., Sauerwein, H. P., & Romijn, J. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1041 · Cited by 46 · cited 2×
“1) In experiments in which body mass is kept constant in normal-weight men[56]or patients with type 2 diabetes[11,13], a very low carbohydrate diet resulted in dramatic improvements in triglycerides and HDL cholesterol with minimal change in body mass.”
BackgroundZammit, V. A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04263.x · Cited by 43 · cited 1×
“Fructose consumption has been implicated in the epidemics of obesity, MetS, and type 2 diabetes and is known to induce hypertension, de novo lipogenesis, hepatic insulin resistance and adiposity [ 52-54 ].”
BackgroundLow carbohydrate diets in family practice: what can we learn from an internet-based support group
Feinman, R. D., Vernon, M. C., & Westman, E. C. (2006) · Nutrition Journal · doi:10.1186/1475-2891-5-26 · Cited by 40 · cited 1×
“Although pessimism exists in the medical community on the efficacy of any diet in the treatment of diabetes 2 and MetS, the success of carbohydrate restriction for many practitioners and individual patients[64] mandates that we should determine how this approach can be consistently and effectively employed.”
BackgroundSelf-citationGood Calories, Bad Calories by Gary Taubes; New York: AA Knopf
Bray, G. A. (2008) · Obesity Reviews · doi:10.1111/j.1467-789x.2008.00476.x · Cited by 30
Clinical Experience of a Carbohydrate-Restricted Diet: Effect on Diabetes Mellitus
Vernon, M. C., Mavropoulos, J. C., Transue, M., Yancy, W. S., & Westman, E. C. (2003) · Metabolic Syndrome and Related Disorders · doi:10.1089/154041903322716714 · Cited by 29 · cited 1×
“Many studies have demonstrated the benefits of carbohydrate reduction [11-16] on glycemic control.”
BackgroundSelf-citationA Pilot Trial of a Low-Carbohydrate, Ketogenic Diet in Patients with Type 2 Diabetes
Yancy, W. S., Vernon, M. C., & Westman, E. C. (2003) · Metabolic Syndrome and Related Disorders · doi:10.1089/154041903322716723 · Cited by 26 · cited 1×
“Many studies have demonstrated the benefits of carbohydrate reduction [ 11-16 ] on glycemic control.”
BackgroundSelf-citationCassady, B. A., Charboneau, N. L., Brys, E. E., Crouse, K. A., Beitz, D. C., & Wilson, T. E. (2007) · Nutrition & Metabolism · doi:10.1186/1743-7075-4-23 · Cited by 26 · cited 1×
“A recent report comparing two low-CHO groups that differed in dietary SFA showed little difference in plasma levels of stearic or palmitic acid [ 49 ].”
BackgroundThe case for not restricting saturated fat on a low carbohydrate diet
Volek, J. S., & Forsythe, C. E. (2005) · Nutrition & Metabolism · doi:10.1186/1743-7075-2-21 · Cited by 21
Self-citationReaven, G. M. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1986.tb07589.x · Cited by 17 · cited 2×
“Response to carbohydrate restriction shows both continuous, graded outcomes [17,18] as well as a threshold effects.”
BackgroundInsulin Resistance from a Low Carbohydrate, High Fat Diet Perspective
Westman, E. C., Yancy, W. S., Haub, M. D., & Volek, J. S. (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.14 · Cited by 15 · cited 1×
“[19] in which 17 of 21 patients with type 2 diabetes reduced or discontinued diabetes medication upon carbohydrate restriction.”
BackgroundSelf-citationGonzález-Ortíz, M., & Martínez‐Abundis, E. (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.3 · Cited by 12
Carbohydrate restriction and cardiovascular risk
Karam, J. G., Nessim, F., McFarlane, S. I., & Feinman, R. D. (2008) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-008-0018-z · Cited by 11 · cited 2×
“Several critical reviews have pointed up the general failure to meet the kind of unambiguous outcomes that would justify blanket condemnation of saturated fat, per se [29,30,41,43,44].”
BackgroundSelf-citationArora, S., & McFarlane, S. I. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-14 · Cited by 8
Self-citation
Research works printed but not linked: 7
- Bernstein R Dr Bernstein's Diabetes Solution: The Complete Guide to Achieving Normal Blood Sugars 2007 Little, Brown and Company
- Vernon MC Eberstein JA Atkins Diabetes Revolution The Groundbreaking Approach to Preventing and Controlling Type 2 Diabetes 2004 New York: William Morrow PMC535347 15535891
- Eades MR Eades MD Protein Power 1996 New York: Bantam Books
- Colpo A The Great Cholesterol Con 2006 Lulu Press
- Ravnskov U The Cholesterol Myths: Exposing the Fallacy that Cholesterol and Saturated Fat Cause Heart Disease 2000 Washington, DC: New Trends Publishing, Inc
- Taubes G Good Calories, Bad Calories 2007 New York: Alfred A. Knopf
- Agatston A The South Beach Diet 2003 New York: Random House
Cited by
Feinman, R. D., Pogozelski, W. K., Astrup, A., Bernstein, R. K., Fine, E. J., Westman, E. C., Accurso, A., Frassetto, L., Gower, B. A., McFarlane, S. I., et al. (2015) · Nutrition · doi:10.1016/j.nut.2014.06.011 · Cited by 912
“It is universally accepted that dietary carbohydrate is the main dietary determinant of blood glucose [7] and restriction shows the greatest reduction in postprandial and overall glucose concentrations as well as HbA 1c [3,6,8 – 14].”
Self-citationBueno, N. B., de Melo, I. S. V., de Oliveira, S. L., & da Rocha Ataide, T. (2013) · British Journal of Nutrition · doi:10.1017/s0007114513000548 · Cited by 778
Franz, M. J., Boucher, J. L., Rutten-Ramos, S., & VanWormer, J. J. (2015) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2015.02.031 · Cited by 672
“Low-carbohydrate and/or highprotein diets have been recommended for better weightloss outcomes in individuals with diabetes.(38,39) To better determine macronutrient composition of weight-loss intervention, a secondary question reviewed five trials comparing different macronutrient percentages and their outcomes.”
BackgroundEffect of diet on type 2 diabetes mellitus: a review
Khazrai, Y. M., Defeudis, G., & Pozzilli, P. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2515 · Cited by 626
“[55], for example, accepted the ADA’s definition that a lowcarbohydrate diet contains less than 130 g carbohydrate per day (i.”
BackgroundCarbohydrate Restriction has a More Favorable Impact on the Metabolic Syndrome than a Low Fat Diet
Volek, J. S., Phinney, S. D., Forsythe, C. E., Quann, E. E., Wood, R. J., Puglisi, M. J., Kraemer, W. J., Bibus, D. M., Fernandez, M. L., & Feinman, R. D. (2009) · Lipids · doi:10.1007/s11745-008-3274-2 · Cited by 397
“Also, in comparative studies in which weight loss is similar between different diets, the carbohydrate-restricted group shows better response on other markers [60, 61].”
BackgroundSelf-citation
Metadata
- Authors
- Accurso, A., Bernstein, R. K., Dahlqvist, A., Draznin, B., Feinman, R. D., Fine, E. J., Gleed, A., Jacobs, D. B., Larson, G., Lustig, R. H., Manninen, A. H., McFarlane, S. I., Morrison, K., Nielsen, J. V., Ravnskov, U., Roth, K. S., Silvestre, R., Sowers, J. R., Sundberg, R., Volek, J. S., Westman, E. C., Wood, R. J., Wortman, J., & Vernon, M. C.
- Affiliations
- SUNY Downstate Health Sciences University (US)
- Albert Einstein College of Medicine (US)
- University of California, San Francisco (US)
- Creighton University (US)
- University of Missouri (US)
- Malmö Municipality (SE)
- University of Connecticut (US)
- Duke Medical Center (US)
- Springfield College (US)
- Health Canada (CA)
- Corresponding author
- Feinman, Richard D
- ORCID
- Venue
- Nutrition & Metabolism
- Published
- 2008-04-08
- Volume
- 5
- Issue
- 1
- Pages
- 9-9
- ISSN
- 1743-7075 (ISSN-L)
- PMC
- PMC2359752
- OpenAlex
- W2168209836
- Cited by
- 263
- References
- 66
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 13 · 2023: 12 · 2022: 15 · 2021: 15 · 2020: 23 · 2019: 13 · 2018: 31 · 2017: 23 · 2016: 16 · 2015: 9 · 2014: 15 · 2013: 13 · 2012: 17
- FWCI
- 9.28
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Nutrition & Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- cIRcle (University of British Columbia) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Open Collections
- Topics
- Health Sciences › Medicine › Physiology (medical) › Diet and metabolism studies
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- carbohydrate restriction, type 2 diabetes, metabolic syndrome, glycemic control, weight loss, low-fat diet, cardiovascular risk, dietary fat reduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.